Keith J. Kendall - CEO and President, Director at Aquestive Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Issuer Symbol
AQST on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Keith J. Kendall since 06 Feb 2025

Holdings reported by Keith J. Kendall for Aquestive Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 636,149 $515,281 $0.8100 26 Aug 2021 Direct
Common Stock 1,000 $810 $0.8100 26 Aug 2021 Custodian of UTMA account for Anna Kendall
Non-Qualified Stock Option (right to buy) 375,000 10 Mar 2022 Direct Common Stock

Transactions reported by Keith J. Kendall for Aquestive Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.